Allogene Therapeutics, Inc.
ALLO
$1.77
-$0.09-4.84%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 332.60M | 266.89M | 250.21M | 252.19M | 273.12M |
| Total Receivables | 2.20M | 1.30M | 1.50M | 2.10M | 1.70M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.20M | 5.11M | 6.04M | 6.43M | 7.84M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 340.00M | 273.29M | 257.75M | 260.72M | 282.66M |
|
|
|||||
| Total Current Assets | 340.00M | 273.29M | 257.75M | 260.72M | 282.66M |
| Net Property, Plant & Equipment | 105.12M | 108.84M | 112.73M | 116.83M | 120.82M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 13.98M | 13.82M | 37.39M | 37.28M | 37.60M |
| Total Assets | 550.09M | 395.96M | 415.91M | 439.77M | 470.59M |
|
|
|||||
| Total Accounts Payable | 5.96M | 4.93M | 4.27M | 3.70M | 4.85M |
| Total Accrued Expenses | 17.11M | 14.98M | 17.64M | 20.13M | 19.07M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.66M | 8.42M | 8.21M | 8.01M | 7.76M |
| Total Finance Division Other Current Liabilities | -- | -- | 2.40M | -- | -- |
| Total Other Current Liabilities | -- | -- | 2.40M | -- | -- |
| Total Current Liabilities | 31.73M | 28.33M | 32.51M | 31.83M | 31.68M |
|
|
|||||
| Total Current Liabilities | 31.73M | 28.33M | 32.51M | 31.83M | 31.68M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 70.35M | 72.63M | 75.05M | 77.13M | 79.24M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.84M | 16.12M | 15.80M | 15.48M | 15.12M |
| Total Liabilities | 113.92M | 117.08M | 123.36M | 124.44M | 126.03M |
|
|
|||||
| Common Stock & APIC | 2.53B | 2.33B | 2.30B | 2.29B | 2.28B |
| Retained Earnings | -2.10B | -2.05B | -2.01B | -1.97B | -1.93B |
| Treasury Stock & Other | -518.00K | -183.00K | 269.00K | 235.00K | -45.00K |
| Total Common Equity | 436.18M | 278.88M | 292.54M | 315.33M | 344.56M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 436.18M | 278.88M | 292.54M | 315.33M | 344.56M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 436.18M | 278.88M | 292.54M | 315.33M | 344.56M |
|
|
|||||